Aarti Pharmalabs Ltd.

The sales for the March 2025 quarter moved up 27.68% to Rs. 5296.24 millions as compared to Rs. 4148.17 millions during the corresponding quarter last year.The company has announced a 40.98% increase in its profits to Rs . 888.46  millions for the  quarter ended March 2025 compared to Rs. 630.19 millions in the corresponding quarter in the previous year.OP of the company witnessed a marginal growth to 1406.22 millions from 1130.31 millions in the same quarter last year.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202503	202403	% Var	202503	202403	% Var	202503	202403	% Var
Sales	5296.24	4148.17	27.68	17713.52	15021.32	17.92	17713.52	15021.32	17.92
Other Income	-25.05	56.88	-144.04	144.90	110.09	31.62	144.90	110.09	31.62
PBIDT	1406.22	1130.31	24.41	4410.34	3571.68	23.48	4410.34	3571.68	23.48
Interest	62.88	44.24	42.13	256.33	166.35	54.09	256.33	166.35	54.09
PBDT	1343.34	1086.07	23.69	4154.01	3405.33	21.99	4154.01	3405.33	21.99
Depreciation	208.31	173.24	20.24	790.59	660.14	19.76	790.59	660.14	19.76
PBT	1135.03	912.83	24.34	3363.42	2745.19	22.52	3363.42	2745.19	22.52
TAX	246.57	282.64	-12.76	789.92	738.74	6.93	789.92	738.74	6.93
Deferred Tax	98.16	165.67	-40.75	222.81	278.17	-19.90	222.81	278.17	-19.90
PAT	888.46	630.19	40.98	2573.50	2006.45	28.26	2573.50	2006.45	28.26
Equity	453.17	453.13	0.01	453.17	453.13	0.01	453.17	453.13	0.01
PBIDTM(%)	26.55	27.25	-2.56	24.90	23.78	4.71	24.90	23.78	4.71